Lexicon Pharmaceuticals(LXRX) - 2025 Q4 - Earnings Call Transcript

Lexicon Pharmaceuticals (NasdaqGS:LXRX) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsCraig Granowitz - SVP and Chief Medical OfficerLisa DeFrancesco - SVP of Investor Relations and Corporate CommunicationsMike Exton - CEO and DirectorScott Coiante - SVP and CFOYigal Nochomovitz - DirectorConference Call ParticipantsJoseph Pantginis - Managing Director and Senior Healthcare AnalystNone - AnalystNone - AnalystNone - AnalystOperatorWelcome to the Lexicon Pharmaceuticals Fourth Quarter a ...